Neurogene Inc. (NGNE) Earnings History
Net Loss15 years of earnings data (2011–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Neurogene Inc. (NGNE) Earnings Overview
As of June 23, 2026, Neurogene Inc. (NGNE) reported trailing twelve-month net income of -$99M, reflecting +0.9% year-over-year growth. The company earned $-4.42 per diluted share over the past four quarters.
Looking at the long-term picture, NGNE's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8M in fiscal 2012.
Neurogene Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KRYS ($225M net income, 52.6% margin), RCKT (-$209M net income), PRAX (-$327M net income), NGNE has comparable earnings metrics. Compare NGNE vs KRYS →
NGNE Earnings vs Peers
Earnings metrics vs comparable public companies
NGNE Historical Earnings Data (2011–2025)
15 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$90M | -20.2% | -$103M | $-4.24 | - | - |
| 2024 | -$75M | -106.9% | -$83M | $-4.28 | -8123.7% | -8930.3% |
| 2023 | -$36M | +34.2% | -$56M | $-2.83 | - | - |
| 2022 | -$55M | -9.2% | -$57M | $-4.30 | - | - |
| 2021 | -$51M | -51.8% | -$51M | $-0.92 | - | - |
| 2020 | -$33M | +52.1% | -$42M | $-0.64 | - | - |
| 2019 | -$69M | -119.9% | -$24M | $-2.57 | - | - |
| 2018 | -$32M | +37.1% | -$24M | $-1.34 | -126.3% | -94.1% |
| 2017 | -$50M | -35.6% | -$51M | $-2.14 | - | - |
| 2016 | -$37M | -69.3% | -$38M | $-1.96 | - | - |
| 2015 | -$22M | +8.2% | -$21M | $-1.73 | - | - |
| 2014 | -$24M | -172.9% | -$22M | $-2.75 | - | - |
| 2013 | -$9M | -13.2% | -$9M | $-0.87 | - | - |
| 2012 | -$8M | +26.6% | -$8M | $-0.77 | - | - |
| 2011 | -$11M | - | -$10M | $-1.05 | - | - |
Download Data
Export NGNE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
15+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NGNE — Frequently Asked Questions
Quick answers to the most common questions about buying NGNE stock.
What is NGNE earnings per share (EPS)?
NGNE trailing twelve-month (TTM) diluted EPS is $-4.42, reflecting +0.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2011 to 2025 is available in the table on this page.
What is Neurogene Inc.'s net income?
Neurogene Inc. (NGNE) trailing twelve-month net income is $-99M as of 2025. Earnings grew +0.9% year-over-year.
Is NGNE profitable?
NGNE is not currently profitable on a TTM basis, reporting a net loss of $-99M. Net margin is N/A. Investors should monitor for a return to profitability.
What is NGNE's earnings growth rate?
NGNE compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2011 to 2025.
What are NGNE's profit margins?
Neurogene Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -31.4%.
Is NGNE growing earnings?
NGNE earnings growth is slowing. Current YoY EPS growth of +0.9% trails the 5-year CAGR of N/A. TTM net income is $-99M.
What was NGNE's best earnings year?
Neurogene Inc.'s highest annual net income on record is $-8M, achieved in fiscal year 2012. Earnings history on this page spans 2011 to 2025 and includes all annual and quarterly figures.
What were NGNE's earnings last quarter?
NGNE's most recent reported quarter was Q1 2026. Net income was $-31M with diluted EPS of $-1.39. For a full breakdown of all quarters, see the quarterly earnings table on this page.